Vanguard Portfolio Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249M Buy
12,365,663
+227,936
+2% +$4.11M 0.01% 1049
2026
Q2
$210M Buy
12,137,727
+812,794
+7% +$11.1M 0.01% 1180
2026
Q1
$141M Buy
+11,324,933
New +$152M 0.01% 1317

Other funds holding AMRX

Vanguard Portfolio Management's AMRX Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Amneal Pharmaceuticals (AMRX) stake by 1.9% in Q3 2026, buying an estimated $4.11M and bringing the position to 12,365,663 shares worth $249M. The position accounts for 0.01% of the portfolio, ranked #1049.

Vanguard Portfolio Management first reported a position in AMRX in Q1 2026 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • Vanguard Portfolio Management held 12,365,663 shares of Amneal Pharmaceuticals worth $249M as of Q3 2026.
  • Vanguard Portfolio Management bought 227,936 Amneal Pharmaceuticals shares in Q3 2026, an estimated $4.11M.
  • Amneal Pharmaceuticals made up 0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1049 holding.
  • Vanguard Portfolio Management first reported a position in Amneal Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.